Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 2, 2024
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
[ Wed, Oct 02nd 2024
] - WOPRAI
Tue, October 1, 2024
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
Yi Chen Reiterated (brns) at Strong Buy and Held Target at $5 on, Oct 1st, 2024
Yi Chen of HC Wainwright & Co., Reiterated "Barinthus Biotherapeutics plc" (BRNS) at Strong Buy and Held Target at $5 on, Oct 1st, 2024.
Yi has made no other calls on BRNS in the last 4 months.
There is 1 other peer that has a rating on BRNS. Out of the 1 peers that are also analyzing BRNS, 0 agree with Yi's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yi
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $3 on, Thursday, June 13th, 2024
